Literature DB >> 2886112

Studies of human retroviruses in relation to adult T-cell leukaemia, acquired immune deficiency syndrome, and multiple sclerosis.

A Karpas, K Malik, J Lida.   

Abstract

Studies of adult T-cell leukaemia virus/human T-cell leukaemia/lymphotropic viruses (ATLV/HTLV-I) in Japan indicate that the virus is involved only with the development of ATL. By contrast, reports from the U.S.A. about HTLV have from time to time claimed that related HTLV are concerned not only with ATL of black persons, but also with a wide range of diseases, such as mycosis fungoides/Sezary's syndrome, T-cell hairy cell leukaemia, acquired immune deficiency syndrome (AIDS) and also multiple sclerosis. Using morphological, biological, serological and molecular hybridisation studies, we were able to confirm that the viruses implicated in the development of ATL and AIDS are distinct and that ATLV/HTLV-I is involved only in ATL, and HIV/LAV/HTLV-III only in AIDS. In vitro, ATLV/HTLV-I transformed and immortalised T-cells, while HIV/LAV/HTLV-III killed our T-cells. Failure to detect any serological cross-reaction indicates that all the structural proteins are different. Likewise, Southern blot studies failed to reveal any cross-hybridisation. Sixty patients with multiple sclerosis failed to reveal any association with ATLV/HTLV-I or with HIV/LAV/HTLV-III. Our conclusion is that ATLV/HTLV-I is involved only in ATL of Japanese and of some black persons of African origin, and that HIV/LAV/HTLV-III is associated only in AIDS.

Entities:  

Mesh:

Year:  1987        PMID: 2886112     DOI: 10.1007/bf01310783

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  28 in total

1.  Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus.

Authors:  P Sonigo; M Alizon; K Staskus; D Klatzmann; S Cole; O Danos; E Retzel; P Tiollais; A Haase; S Wain-Hobson
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

2.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

3.  Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study.

Authors:  Y Hinuma; H Komoda; T Chosa; T Kondo; M Kohakura; T Takenaka; M Kikuchi; M Ichimaru; K Yunoki; I Sato; R Matsuo; Y Takiuchi; H Uchino; M Hanaoka
Journal:  Int J Cancer       Date:  1982-06-15       Impact factor: 7.396

4.  Adult T-cell lymphoma-leukaemia in Blacks from the West Indies.

Authors:  D Catovsky; M F Greaves; M Rose; D A Galton; A W Goolden; D R McCluskey; J M White; I Lampert; G Bourikas; R Ireland; A I Brownell; J M Bridges; W A Blattner; R C Gallo
Journal:  Lancet       Date:  1982-03-20       Impact factor: 79.321

5.  Antigens on HTLV-infected cells recognized by leukemia and AIDS sera are related to HTLV viral glycoprotein.

Authors:  J Schüpbach; M G Sarngadharan; R C Gallo
Journal:  Science       Date:  1984-05-11       Impact factor: 47.728

6.  Homology of genome of AIDS-associated virus with genomes of human T-cell leukemia viruses.

Authors:  S K Arya; R C Gallo; B H Hahn; G M Shaw; M Popovic; S Z Salahuddin; F Wong-Staal
Journal:  Science       Date:  1984-08-31       Impact factor: 47.728

7.  Unique cell lines harbouring both Epstein-Barr virus and adult T-cell leukaemia virus, established from leukaemia patients.

Authors:  N Yamamoto; T Matsumoto; Y Koyanagi; Y Tanaka; Y Hinuma
Journal:  Nature       Date:  1982-09-23       Impact factor: 49.962

Review 8.  Human T-lymphotropic retroviruses.

Authors:  F Wong-Staal; R C Gallo
Journal:  Nature       Date:  1985 Oct 3-9       Impact factor: 49.962

9.  Multiple sclerosis and human T-cell lymphotropic retroviruses.

Authors:  H Koprowski; E C DeFreitas; M E Harper; M Sandberg-Wollheim; W A Sheremata; M Robert-Guroff; C W Saxinger; M B Feinberg; F Wong-Staal; R C Gallo
Journal:  Nature       Date:  1985 Nov 14-20       Impact factor: 49.962

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  6 in total

1.  Multicenter evaluation of the novel ABN Western blot (immunoblot) system in comparison with an enzyme-linked immunosorbent assay and a different Western blot.

Authors:  B Weber; G Hess; R Enzensberger; F Harms; C J Evans; A Hamann; H W Doerr
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

2.  Comparison of immunofluorescence, enzyme immunoassay, and Western blot (immunoblot) methods for detection of antibody to human T-cell leukemia virus type I.

Authors:  D Gallo; M N Hoffman; C K Cossen; J L Diggs; J W Hurst; L M Penning
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

3.  Investigation of atypical western blot (immunoblot) reactivity involving core proteins of human immunodeficiency virus type.

Authors:  S L Josephson; N S Swack; M T Ramirez; W J Hausler
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

4.  Human spumaretrovirus antibody reactivity in multiple sclerosis.

Authors:  J Lycke; B Svennerholm; A Svenningsson; W Muranyi; R M Flügel; O Andersen
Journal:  J Neurol       Date:  1994-02       Impact factor: 4.849

5.  Phenotypic and genotypic comparisons of human T-cell leukemia virus type 1 reverse transcriptases from infected T-cell lines and patient samples.

Authors:  Michael S Mitchell; Ellen T Bodine; Shawn Hill; Gerald Princler; Patricia Lloyd; Hiroaki Mitsuya; Masao Matsuoka; David Derse
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

Review 6.  Differential diagnosis of human retrovirus infections in the laboratory.

Authors:  B P Griffith
Journal:  Yale J Biol Med       Date:  1989 Mar-Apr
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.